Multiple endocrine neoplasia type 1 (MEN1) provides a prime example of how
a rare disease can advance our understanding of basic cell biology, neoplas
ia and common endocrine tumors. MEN1 is expressed mainly as parathyroid, en
teropancreatic neuroendocrine, anterior pituitary and foregut carcinoid tum
ors. It is an autosomal dominant disease caused by mutation of the MEN1 gen
e. Since its identification, the MEN1 gene has been implicated in many comm
on endocrine and non-endocrine tumors. This is a brief overview of recent s
cientific advances relating to MEN1, including newly recognized clinical fe
atures that are now better characterized by genetic analysis, insights into
the function of the MEN1-encoded protein menin, and refined recommendation
s for mutation testing and tumor screening, which highlight our increasing
understanding of this complex syndrome.